Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-006297-23-GB
EUCTR2006-006297-23-GB
Active, not recruiting
Phase 1

A study of the pharmacokinetics of new formulation lopinavir/ritonavir in the genital tract and plasma of HIV infected women in pregnancy

Guy's & St Thomas' NHS Foundation Trust0 sites10 target enrollmentJanuary 12, 2009
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsKaletra tablets

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Guy's & St Thomas' NHS Foundation Trust
Enrollment
10
Status
Active, not recruiting
Last Updated
7 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 12, 2009
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
Female

Investigators

Sponsor
Guy's & St Thomas' NHS Foundation Trust

Eligibility Criteria

Inclusion Criteria

  • •1\) HIV antibody positive
  • •2\) 18 years and over
  • •3\) pregnant
  • •4\) Tolerating a lopinavir/ritonavir based regimen in pregnancy
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) no
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •1\) Less than 18 years of age
  • •2\) Taking medication known to interfere with lopinavir
  • •3\) Unable to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Pharmacokinetic evaluation of a new formulation of recombinant factor IX (BeneFIX) in the italian population with severe or moderate B haemophilia previously treated. - NDPatients with severe or moderate B Haemophilia, previously treated with rFIX.MedDRA version: 9.1Level: SOCClassification code 10010331
EUCTR2008-006465-85-ITAZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI
Withdrawn
Not Applicable
A Phase 1 Pharmacokinetic-Pharmacodynamic Study of Avelumab (MSB00100718C) in Patients with Previously Treated Advanced Stage Classical Hodgkin*s LymphomaHodgkin's Lymphomalymph node cancer10025319
NL-OMON43446Pfizer15
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Daptomycin.Infectious Disease
JPRN-UMIN000017226Keio University20
Recruiting
Not Applicable
Study on Pharmacokinetics and Pharmacodynamics of high dose Meropenem.infectious disease
JPRN-UMIN000017225Keio University20
Recruiting
Not Applicable
Bioequivalence Study of Somatropin in Healthy Human Volunteers..
IRCT20130626013776N20AryaTinaGene Biopharmaceutical Co30